191 completed, 58 unknown, 15 terminated, 10 recruiting. 155 Not applicable, 30 Phase 4, 20 Phase 2, 19 Phase 3, 12 Phase 1.
Follow Type2 Diabetes: new trials by email Literature Review of Type2 Diabetes trials Research Report on Type2 Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diabetes Prevention AI: Enhancing Prevention Strategies Using Personalized Nutrition and Fitness Coaching for the Next Generation AI-Powered Diabetes Prevention Chatbot - Pre Diabetes, Type2 Diabetes | Not applicable | Not yet recruiting | Emory University | 30 | 2026-10-01 | 2026-09-17 |
| Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention DPP only, Diabetes Prevention Program (DPP) online + doula divas - Gestational Diabetes, Type2 Diabetes | Not applicable | Withdrawn | Vanderbilt University Medical Center | 2025-01-31 | 2025-08-15 | |
| A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients. Efsubaglutide Alfa Injection - Type2 Diabetes | Phase 2 | Completed | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 59 | 2024-12-18 | 2025-09-12 |
| Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education PICC Program, Control - Diabetes Mellitus, Type2 Diabetes | Not applicable | Completed | Clinical Research Centre, Malaysia | 94 | 2023-05-01 | 2024-02-16 |
| Protective Cooling Measures to Safeguard Elderly People From Dangerous Summer Heat No cooling (control), Recommended cooling, Hybrid cooling - Hyperthermia, Heat; Weather | Not applicable | Unknown | University of Ottawa | 60 | 2023-05-01 | 2022-10-21 |
| First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy HbA1c, serum creatinine, eGFR urine analysis and serum electrolyte Na and K - SGLT2 Inhibitors, First Time Use, Type2 Diabetes | Not applicable | Completed | Sohag University | 60 | 2023-04-25 | 2024-04-17 |
| OP5-005 Using Omnipod 5 in Adults With Type 2 Omnipod 5 Automated Glucose Control System - Type2 Diabetes | Not applicable | Completed | Insulet Corporation | 343 | 2023-04-11 | 2025-09-29 |
| The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT Tele-Nursing based Motivational Interviewing - Type2 Diabetes, Self Efficacy | Not applicable | Completed | Pamukkale University | 70 | 2023-02-01 | 2024-03-13 |
| Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) Probiotic lysate (postbiotic and metabiotic), Placebo - Obesity, Obesity, Abdominal | Not applicable | Completed | Bogomolets National Medical University | 55 | 2023-02-01 | 2024-04-03 |
| Feasibility of Yoga for Type-2 Diabetes Iyengar yoga, Standard Exercise, Nutrition Counseling - Type2 Diabetes | Not applicable | Completed | The Miriam Hospital | 73 | 2022-10-24 | 2025-04-23 |
| Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes Bariatric Surgery - Type2 Diabetes, NAFLD | Completed | University of Nottingham | 21 | 2022-07-01 | 2025-04-29 | |
| A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH MSDC-0602K, Placebo - Type2 Diabetes, NASH - Nonalcoholic Steatohepatitis | Phase 3 | Unknown | Cirius Therapeutics, Inc. | 1800 | 2022-06-01 | 2021-07-12 |
| UK Imaging Diabetes Study Seeing Diabetes Clearly MRI - Type2 Diabetes | Recruiting | Perspectum | 1000 | 2022-05-30 | 2025-12-05 | |
| Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) Observational - Type2 Diabetes, Type 2 Diabetes Mellitus in Obese | Recruiting | Washington University School of Medicine | 117 | 2022-05-24 | 2025-12-18 | |
| A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo - Type2 Diabetes, Diabetes Mellitus | Phase 3 | Completed | Eli Lilly and Company | 99 | 2022-04-13 | 2025-09-26 |
| Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus. Metformin, Dapagliflozin, Lifestyle intervention - Type2 Diabetes | Early Phase 1 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 120 | 2022-04-01 | 2022-03-16 |
| The Mobile Lifestyle Intervention for Food and Exercise Study Podcasts and tips of the day (within app), mLIFE app (self-regulation features), mLIFE app (social support features) - Overweight and Obesity, Type2 Diabetes | Not applicable | Completed | University of South Carolina | 243 | 2022-03-01 | 2026-01-15 |
| Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes Multi-Detector Computed Tomography - Type2 Diabetes, Coronary Heart Disease | Not applicable | Enrolling by invitation | JuFeng, Hsiao | 2000 | 2022-03-01 | 2022-05-06 |
| Diabetic Retinopathy Screening in General Practice Diabetic Retinopathy Screening - Diabetic Retinopathy, Type2 Diabetes | Completed | Aalborg University | 300 | 2022-02-28 | 2025-05-06 | |
| Association of Bisphenol A,Paraben Exposure and Type 2 Diabetes HPLC - Type2 Diabetes, Bisphenol A | Not applicable | Unknown | Cairo University | 100 | 2022-02-20 | 2022-07-27 |
Showing 20 of 291. Sign in to see all of them.
Diabetes Mellitus, Type 2 (69) · Obesity (35) · Diabetes Mellitus (22) · Insulin Resistance (21) · Non-alcoholic Fatty Liver Disease (16) · Motor Activity (11) · Overweight (10) · Cardiovascular Diseases (7) · Heart Failure (7) · Hypertension (7) · Prediabetic State (7) · Atherosclerosis (6) · Diabetes, Gestational (5) · Diabetic Nephropathies (5) · Hyperglycemia (5)
Nutritional and Metabolic Diseases (141) · Metabolic Diseases (121) · Glucose Metabolism Disorders (110) · Endocrine System Diseases (96) · Diabetes Mellitus (75) · Pathological Conditions, Signs and Symptoms (62) · Signs and Symptoms (48) · Body Weight (43) · Nutrition Disorders (42) · Overnutrition (41) · Overweight (31) · Cardiovascular Diseases (26) · Hyperinsulinism (25) · Vascular Diseases (24) · Behavior (20)
dapagliflozin (14) · Metformin (8) · empagliflozin (8) · Exercise (6) · Dipeptidyl-Peptidase IV Inhibitors (5) · Sitagliptin Phosphate (5) · Continuous Glucose Monitoring (4) · Exenatide (4) · Linagliptin (4) · Liraglutide (4) · Pioglitazone (4) · Sodium-Glucose Transporter 2 Inhibitors (4) · glimepiride (4) · 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (3) · Bariatric Surgery (3)
Dong-A ST Co., Ltd. (7) · Nanjing First Hospital, Nanjing Medical University (6) · Bogomolets National Medical University (5) · Chong Kun Dang Pharmaceutical (4) · Mayo Clinic (4) · University Hospital, Gentofte, Copenhagen (4) · Copenhagen University Hospital, Rigshospitalet (3) · India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals (3) · NYU Langone Health (3) · Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (3) · University of Southern Denmark (3) · Arizona State University (2) · Brigham and Women's Hospital (2) · Cairo University (2) · Colorado State University (2)
United States (86) · Denmark (23) · China (18) · South Korea (17) · Canada (13) · France (13) · United Kingdom (11) · Finland (7) · Germany (7) · India (7) · Egypt (6) · Israel (5) · Netherlands (5) · Sweden (5) · Turkey (Türkiye) (5)
Anne-Maria Pajari, PhD (2) · BongSoo Cha, Ph.D (2) · Leonie Heilbronn, PhD (2) · Ma Jianhua (2) · Nazarii Kobyliak, PhD (2) · Petro Bodnar, Prof (2) · Sung Dae Kwon, M.D., Ph.D. (2) · Uthai Suvanakoot (2) · Alessio Bricca, MSc, PhD (1) · Alexandra Kautzky-Willer, Prof. Dr. (1) · Ali K M.Sami, Ph.D. (1)
PMID 39961992, PMID 40004948, PMID 16083707, PMID 1678444, PMID 248266, PMID 25340784, PMID 26242184, PMID 26732026, PMID 27079342, PMID 27095829, PMID 27466607, PMID 27608829, PMID 28086870, PMID 28246291, PMID 28724646, PMID 28956082, PMID 29358950, PMID 29386249, PMID 29635498, PMID 29661605, PMID 29723506, PMID 29917105, PMID 29935107, PMID 30221912, PMID 30224284, PMID 30291068, PMID 30342298, PMID 30614187, PMID 30659076, PMID 30684076, PMID 30823909, PMID 30826792, PMID 30904742, PMID 30954510, PMID 30967436, PMID 30968140, PMID 31221693, PMID 31276156, PMID 31335198, PMID 31405646, PMID 31413841, PMID 31426060, PMID 31453424, PMID 31475297, PMID 31529056, PMID 31673295, PMID 31694682, PMID 31753900, PMID 31855189, PMID 32337475
2017 (2), 2016 (1), 2019 (1), K01DK116923 (1), K01HL140278 (1), K24HL103845 (1), R00MD012811 (1), R01DK111604 (1), R01DK113999 (1), R01DK126826 (1), R01DK128900 (1), R01DK129302 (1), R01HL111465 (1), R01HL142250 (1), R01HL143792 (1)